Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. |
|  | | 03/09/10 | Cepheid to Webcast Upcoming Financial Presentation| SUNNYVALE, Calif., March 9, 2010 /PRNewswire via COMTEX/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast.
Barclays Capital Global Healthcare Conference, Miami, FL
Tuesday, March 23, 2010 at 3.15 p.m. Eastern Time
To access the live webcast for this event, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled ... |
| | 01/28/10 | Cepheid Reports Fourth Quarter and Full Year 2009 Results| Test Menu Expansion Drives Full Year Clinical Business Growth of 28%SUNNYVALE, Calif., Jan 28, 2010 /PRNewswire via COMTEX/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2009 of $49.2 million. Net loss was $4.3 million, or $(0.07) per share, which compares to revenue of $37.8 million and a net loss of $6.0 million, or $(0.10) per share, in the fourth quarter of fiscal 2008. Excluding amortization of purchased intangible assets and stock compensation expenses, non-... |
|
|
|
|  | Q409 Results Q409 Earnings Call Q309 10Q 2008 10K 2008 Annual Report ASM ResultsQ409 Results & Supplementary Data
 Q409 Fact Sheet

 On-Demand Report |